VYNE THERAPEUTICS INC.

(VYNE)
  Rapport
Temps Différé Nasdaq  -  20/05 22:00:01
0.4001 USD   +0.15%
12/05Earnings Flash (VYNE) VYNE THERAPEUTICS annonce un revenu de 178 000 $ pour le premier trimestre.
MT
12/05VYNE Therapeutics Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
CI
08/04MISE À JOUR SECTORIELLE : Les actions du secteur de la santé sont en hausse vendredi avant le marché
MT
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur VYNE THERAPEUTICS INC.
18/05VYNE Therapeutics to Present at HC Wainwright & Co. Global Investment Conference
17/05VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
17/05TRANSCRIPT : VYNE Therapeutics Inc. - Special Call
12/05VYNE THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and..
12/05Earnings Flash (VYNE) VYNE THERAPEUTICS Reports Q1 Loss $-0.14
12/05Earnings Flash (VYNE) VYNE THERAPEUTICS Reports Q1 Revenue $178,000
12/05VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2..
12/05VYNE Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Up..
12/05NORTH AMERICAN MORNING BRIEFING : Stocks Seen -3-
10/05VYNE Hosting Key Opinion Leader Event on Novel InhiBET™ BET Inhibitor Platform
06/05VYNE Therapeutics to Present at LifeSci Partners' Immunology & Inflammation Symposium o..
08/04SECTOR UPDATE : Health Care Stocks Edge Upward Premarket Friday
07/04VYNE Therapeutics Reports 'Positive' Efficacy Results From Phase 1b Portion of Atopic D..
07/04VYNE THERAPEUTICS : Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a ..
07/04VYNE THERAPEUTICS INC. : Changes in Registrant's Certifying Accountant, Other Events, Fina..
07/04VYNE Therapeutics Reports Positive Efficacy Results From Phase 1B Study of FMX114 to Tr..
07/04VYNE Therapeutics Announces Positive Phase 1b Efficacy Data for FMX114 from Phase 1b/2a..
07/04VYNE Therapeutics Inc. Announces Positive Phase 1b Efficacy Data for FMX114 from Phase ..
30/03VYNE Therapeutics Says Preclinical Data Back Further Development of Experimental Joint ..
30/03VYNE THERAPEUTICS : Reports Positive Preclinical Data for Intra-Articular Injection of Pan..
30/03VYNE THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
30/03VYNE Reports Positive Preclinical Data for Intra-Articular Injection of Pan-BET Inhibit..
30/03VYNE Therapeutics Inc. Reports Positive Preclinical Data for Intra-Articular Injection ..
21/03VYNE THERAPEUTICS INC.(NASDAQGS : VYNE) dropped from S&P Global BMI Index
17/03VYNE THERAPEUTICS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
17/03VYNE THERAPEUTICS : Reports Year-End 2021 Financial Results and Provides Corporate Update ..
17/03Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q4 Revenue $2.29M
17/03VYNE Therapeutics Reports Year-End 2021 Financial Results and Provides Corporate Update
17/03Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q4 Loss $-0.20
17/03VYNE Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 3..
17/03VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 20..
17/03VYNE Therapeutics Inc. Auditor Raises 'Going Concern' Doubt
15/03VYNE THERAPEUTICS INC. : Entry into a Material Definitive Agreement, Change in Directors o..
15/03VYNE Therapeutics Inc. Appoints Tyler Zeronda as the Chief Financial Officer
15/03VYNE Therapeutics Inc. Names Tyler Zeronda as Treasurer
08/03VYNE THERAPEUTICS INC. : Regulation FD Disclosure (form 8-K)
07/03VYNE Therapeutics Says Drug Candidate Reduces Biomarkers in Preclinical Data in Human S..
07/03VYNE THERAPEUTICS : Reports Positive Preclinical Data for Lead BET Inhibitor, VYN201, in H..
07/03VYNE THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
07/03VYNE Reports Positive Preclinical Data for Lead BET Inhibitor, VYN201, in Human Skin Mo..
07/03VYNE Therapeutics Inc. Reports Positive Preclinical Data for Lead Bet Inhibitor, VYN201..
04/03VYNE THERAPEUTICS INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rul..
03/03VYNE Therapeutics to Present at 42nd Annual Cowen Healthcare Conference
03/03NORTH AMERICAN MORNING BRIEFING : Oil Prices Top -3-
19/01VYNE Therapeutics Completes Phase 1b Data for FMX114 for Atopic Dermatitis
19/01VYNE THERAPEUTICS : Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Trea..
19/01VYNE THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
19/01VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Tre..
19/01VYNE Therapeutics Inc. Announces Phase 1B Data for Fmx114 from Phase 1B/2A Trial for th..
14/01VYNE THERAPEUTICS : Unaudited Pro Forma Condensed Consolidated Financial Information - For..
14/01VYNE THERAPEUTICS INC. Change in Directors or Principal Officers, Financial Statements..
14/01VYNE Therapeutics Inc. Announces Board Changes
14/01Health Care Stocks Drop Premarket Friday
13/01Health Care Stocks Losing More Ground as Biotechs Sputter in Late Trade
13/01SECTOR UPDATE : Health Care
13/01Top Midday Decliners
13/01Wall Street Set for Narrow Gains; US Wholesale Prices Rise Less Than Expected in Decemb..
13/01Thinking about buying stock in Adagio Therapeutics, Vyne Therapeutics, PetVivo, BTCS In..
13/01Top Premarket Gainers
13/01Journey Medical Acquires Vyne Therapeutics' Molecule Stabilizing Technology Franchise
13/01VYNE THERAPEUTICS : Divests Topical Minocycline Assets - Form 8-K
13/01VYNE THERAPEUTICS INC. : Entry into a Material Definitive Agreement, Completion of Acquisi..
13/01VYNE Therapeutics Divests Topical Minocycline Assets
13/01Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and ..
05/01VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
03/01VYNE Therapeutics to Participate at the LifeSci Partners 11th Annual Corporate Access E..
2021VYNE THERAPEUTICS INC.(NASDAQGS : VYNE) dropped from NASDAQ Biotechnology Index
2021Top Premarket Gainers
2021VYNE Therapeutics Shares Surge After HC Wainwright Starts Coverage at Buy
2021Thinking about buying stock in Del Taco Restaurants, Vyne Therapeutics, Lucid Group, AS..
2021VYNE Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Confer..
2021VYNE THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and..
2021TRANSCRIPT : VYNE Therapeutics Inc., Q3 2021 Earnings Call, Nov 10, 2021
2021VYNE Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months E..
2021VYNE Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Up..
1  2  3  4  5  6  7  8Suiv.
Prochain événement sur VYNE THERAPEUTICS INC.